| Identification | Back Directory | [Name]
2H-Pyran-4-carboxamide, 4-amino-N-[(1S,2E)-4-(2,3-dihydro-1H-indol-1-yl)-1-(2-methylpropyl)-4-oxo-2-buten-1-yl]tetrahydro- | [CAS]
1613458-71-1 | [Synonyms]
GSK2793660 free base
2H-Pyran-4-carboxamide, 4-amino-N-[(1S,2E)-4-(2,3-dihydro-1H-indol-1-yl)-1-(2-methylpropyl)-4-oxo-2-buten-1-yl]tetrahydro- | [Molecular Formula]
C22H31N3O3 | [MOL File]
1613458-71-1.mol | [Molecular Weight]
385.5 |
| Hazard Information | Back Directory | [Uses]
Propyl-GSK2793660 is a potent cathepsin C inhibitor that holds potential for treating cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis, and bronchiectasis. | [References]
[1] Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986) |
|
|